Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced NSCLC With EGFR Mutation × S 1 (combination) × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 NSCLC 2 Stomach Neoplasms 1 Radiation Injuries 1 Pancoast Syndrome 1 Non-small Cell Lung Cancer Stage Ⅱ 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced Non-Small Cell Lung Cancer 1 Advanced NSCLC With EGFR Mutation 1

Interventions

S 1 (combination) 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Henan Cancer Hospital

Phase 2 Unknown

Advanced NSCLC With EGFR Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡